Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease

CompletedOBSERVATIONAL
Enrollment

441

Participants

Timeline

Start Date

May 6, 2018

Primary Completion Date

March 27, 2023

Study Completion Date

March 29, 2023

Conditions
REM Sleep Behavior Disorder
Interventions
DIAGNOSTIC_TEST

Colonoscopy

All subjects will undergo standard mechanical bowel preparation with 4 liters of polyethylene glycol (Klean-Prep, Norgine Ltd., Middlesex, UK). Total colonoscopy will be performed by experienced endoscopists under conscious sedation with intravenous benzodiazepines and narcotics. A conventional intermediate-length colonoscope (Olympus Corporation, Tokyo, Japan) will be used. One mucosal biopsy will be taken in the descending colon. Biopsies will be performed using standard biopsy forces without needle (Olympus Corporation, Tokyo, Japan). Half of the samples will be immersed in 4 oC normal saline solution. All samples will be immediately sent to pathology department and will be stored in a -80 oC freeze for processing of microbiota analyses.

Trial Locations (2)

Unknown

The Chinese University of Hong Kong, Hong Kong

Shatin Hospital, Shatin

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT03645226 - Gut Microbiota Across Early Stages of Synucleinopathy: From High-risk Relatives, REM Sleep Behavior Disorder to Early Parkinson's Disease | Biotech Hunter | Biotech Hunter